Skip to main content
SpringerLink
Log in

Peyronie’s Disease: Surgical Therapy

  • Chapter
  • First Online:
Contemporary Treatment of Erectile Dysfunction

Part of the book series: Contemporary Endocrinology ((COE))

  • 1042 Accesses

Abstract

Peyronie’s disease (PD) is characterized by scarring and alteration of the intricate architecture of the tunica albuguinea of the penis. This anatomic deformity may cause an abnormal penile curvature toward the site of scarring, cosmetic displease, painful erections during the active phase, and erectile dysfunction (ED) that in some may preclude sexual intercourse. The earliest descriptions of the condition in the Western literature are attributed to Guilielmus de Salicetum (1210–1276) and Theodoric Borgognoni (1205–1298) who are said to have described penile curvature in medical and anatomical textbooks. The symptomatic incidence of PD is estimated at 1–5 % while the asymptomatic incidence is at 0.4–1 %, mostly affecting men 45–60 years of age with an average age of 53 years. To date, most medical and herbal therapies have achieved suboptimal penile straightening and satisfaction rates in the vast majority of patients. In those with failed medical or conservative therapies, surgical interventions have shown great promise with excellent results.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Musitelli S, Bossi M, Jallous H. A brief historical survey of “Peyronie’s disease”. J Sex Med. 2008;5(7):1737–46.

    Article  PubMed  Google Scholar 

  2. de la Peyronie F. Sur quelques obstacles qui s’opposent a l’ejaculation naturelle de la semence. Memoir’Acad Chirurg. 1743;1:318.

    Google Scholar 

  3. Mulhall J, et al. Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening. J Urol. 2004;171:2350–3.

    Article  PubMed  Google Scholar 

  4. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie’s disease: results of a large survey. BJU Int. 2001;88(7):727–30.

    Article  CAS  PubMed  Google Scholar 

  5. Kadioglu A, et al. A retrospective review of 307 men with Peyronie's disease. J Urol. 2002;168:1075–9.

    Article  PubMed  Google Scholar 

  6. Devine CJ, Somers KD, Jordan SG, Schlossberg SM. Proposal: trauma as the cause of the Peyronie’s lesion. J Urol. 1997;157:285–90.

    Article  PubMed  Google Scholar 

  7. Carson CC, Jordan GH, Gelbard MK. Peyronie’s disease: new concepts in etiology, diagnosis and treatment. Contemp Urol. 1999;11:44–64.

    Google Scholar 

  8. Pryor JP, Farrell CR. Controlled clinical trial of vitamin E in Peyronie’s disease. Progr Reprod Biol Med. 1983;9:41–5.

    Google Scholar 

  9. Akkus E, Carrier S, Rehman J, et al. Is colchicine effective in Peyronie’s disease? A pilot study. Urology. 1994;44:291–5.

    Article  CAS  PubMed  Google Scholar 

  10. Hasche-Klunder R. Treatment of Peyronie’s disease with para-aminobenzoacidic potassium (Potaba). Urology. 1978;17:224–7.

    CAS  Google Scholar 

  11. Weidner W, Hauck EW, Schnitker J. Peyronie’s disease Study Group of Andrological Group of German Urologists: potassium paraaminobenzoate (POTABA) in the treatment of Peyronie’s disease – a prospective, placebo-controlled, randomized study. Eur Urol. 2005;47:530–6.

    Article  CAS  PubMed  Google Scholar 

  12. Biagiotti G, Cavallini G. Acetyl-l-carnitine vs tamoxifen in the oral therapy of Peyronie’s disease: a preliminary report. BJU Int. 2001;88:63–7.

    Article  CAS  PubMed  Google Scholar 

  13. Cavallini G, Biagiotti G, Koverech A, Vitali G. Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie’s disease. BJU Int. 2002;89:895–900.

    Article  CAS  PubMed  Google Scholar 

  14. Levine LA, Goldman KE, Greenfield JM. Experience with intraplaque injection of verapamil for Peyronie’s disease. J Urol. 2002;168:621–5. Discussion 625–626.

    Article  CAS  PubMed  Google Scholar 

  15. Gelbard MK, James K, Riach JN, Dorey F. Collagenase versus placebo in the treatment of Peyronie’s disease: a double-blind study. J Urol. 1993;149:56–8.

    CAS  PubMed  Google Scholar 

  16. Jordan GH. The use of intralesional clostridial collagenase injection therapy for Peyronie’s disease: a prospective, single center, non-placebo-controlled study. J Sex Med. 2007;5(1):180–7.

    Article  Google Scholar 

  17. Hakim LS, Khater U. Non-surgical management of Peyronie’s curvature: experience using intralesional Intron-A therapy [abstract 72]. J Sex Med. 2004;1:51.

    Google Scholar 

  18. Bodner H, Howard AH, Kaplan JH. Peyronie’s disease: cortisone-hyaluronidase-hydrocortisone therapy. J Urol. 1954;72:400–3.

    CAS  PubMed  Google Scholar 

  19. Butz M, Teichert HM. Treatment of Peyronie’s disease by extracorporeal shock waves abstract. J Urol. 1998;159(Suppl):118.

    Google Scholar 

  20. Moreland RB, Nehra A. Pathophysiology of Peyronie’s disease. Int J Impot Res. 2002;14:406–10.

    Article  CAS  PubMed  Google Scholar 

  21. Van de Water L. Mechanisms by which fibrin and fibronectin appear in healing wounds: implications for Peyronie’s disease. J Urol. 1997;157:306–10.

    Article  PubMed  Google Scholar 

  22. Somers KD, Dawson DM. Fibrin deposition in Peyronie’s disease plaque. J Urol. 1997;157:311–5.

    Article  CAS  PubMed  Google Scholar 

  23. Pryor JP, Ralph DJ. Clinical presentation of Peyronie’s disease. Int J Impot Res. 2002;14:414–7.

    Article  CAS  PubMed  Google Scholar 

  24. Ralph DJ, et al. The Nebit operation for Peyronie’s disease: 16 year experience. J Urol. 1995;154(4):1362–3.

    Article  CAS  PubMed  Google Scholar 

  25. Rolle L, et al. The Nesbit operation for penile curvature: an easy and effective technical modification. J Urol. 2005;173(1):173–4.

    Article  Google Scholar 

  26. Licht M, et al. Modified Nesbit procedure for the treatment of Peyronie’s disease: a comparative outcome analysis. J Urol. 1997;158:460–3.

    Article  CAS  PubMed  Google Scholar 

  27. Essed E, Schroeder FH. New surgical treatment for Peyronie’s disease. Urology. 1985;25:582.

    Article  CAS  PubMed  Google Scholar 

  28. Gholami S, Lue T. Correction of penile curvature using the 16-DOT plication technique: a review of 132 patients. J Urol. 2002;167:2066–9.

    Article  PubMed  Google Scholar 

  29. Yachia D. Modified corporoplasty for the treatment of penile curvature. J Urol. 1990;143:80–2.

    CAS  PubMed  Google Scholar 

  30. Lopes I, et al. Penile corporoplasty with Yachia’s technique for Peyronie’s disease: single center experience with 117 patients. Urol Ann. 2013;5:167–71.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Craatz S, et al. The dorsal lamina of the rectus sheath: a suitable grafting material for the penile tunica albuginea in Peyronie’s disease? BJU Int. 2006;97:134–7.

    Article  PubMed  Google Scholar 

  32. Goyal NK, et al. Experience with plaque excision and dermal grafting in the surgical treatment of Peyronie’s disease. Singapore Med J. 2008;49:805–8.

    CAS  PubMed  Google Scholar 

  33. ElSakka AI, et al. Venous patch graft for Peyronie’s disease. Part II: outcome analysis. J Urol. 1998;160:2050–3.

    Article  CAS  Google Scholar 

  34. Salem E, Elkady E, et al. Lingual mucosal graft treatment of Peyronie’s disease. Urology. 2014;84(6):1374–7.

    Article  PubMed  Google Scholar 

  35. Carson CC, Chun JL. Peyronie’s disease: surgical management: autologous materials. J Sex Med. 2012;14(5):329–35.

    Google Scholar 

  36. Kalsi J, et al. The results of plaque incision and venous grafting (Lue procedure) to correct the penile deformity of Peyronie’s disease. BJU Int. 2005;95(7):1029–33.

    Article  PubMed  Google Scholar 

  37. Montorsi F, et al. Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie’s disease. J Urol. 2000;163(6):1704–8.

    Article  CAS  PubMed  Google Scholar 

  38. Carson GC. Penile prosthesis implantation in the treatment of Peyronie’s disease and erectile dysfunction. Int J Impot Res. 2000;12:S122–6.

    Article  PubMed  Google Scholar 

  39. Wilson SK, Delk II JR. A new treatment for Peyronie’s disease: modeling the penis over an inflatable penile prosthesis. J Urol. 1994;152:1121–3.

    CAS  PubMed  Google Scholar 

  40. Mulcahy JJ, Wilson SK. Management of Peyronie’s disease with penile prostheses. Int J Impot Res. 2002;14:384–8.

    Article  CAS  PubMed  Google Scholar 

  41. Chung E. Comparison between AMS 700 CX and coloplast titan inflatable penile prosthesis for Peyronie’s disease treatment and remodeling: clinical outcomes and patient satisfaction. J Sex Med. 2013;10:2855–60.

    Article  PubMed  Google Scholar 

  42. Chung P, Scott J, Morey A. High patient satisfaction of inflatable penile prosthesis insertion with synchronous penile plication for erectile dysfunction and Peyronie's disease. J Sex Med. 2014;11:1593–8.

    Article  PubMed  Google Scholar 

  43. Carson CC, Levine L. Outcomes of surgical treatment of Peyronie’s disease. BJU Int. 2014;113:704–13.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The authors would like to thank Dr. Peter Hinds for his contribution to this chapter in the first edition.

Author information

Authors and Affiliations

  1. Department of Urology, University Hospital, 140 Bergen Street, ACC Building Suite G-1680, Newark, NJ, 07103, USA

    Lorenzo DiGiorgio MD & Hossein Sadeghi-Nejad MD, FACS

  2. Division of Urology, Department of Surgery, Rutgers New Jersey Medical School and Hackensack University Medical Center, Hackensack, NJ, USA

    Hossein Sadeghi-Nejad MD, FACS

Authors
  1. Lorenzo DiGiorgio MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hossein Sadeghi-Nejad MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lorenzo DiGiorgio MD .

Editor information

Editors and Affiliations

  1. Southern Illinois University School of Medicine, Springfield, Illinois, USA

    Tobias S. Köhler

  2. Division of Urology Department of Surgery, Southern Illinois University School of Medicine Hospital Affiliates, Springfield, Illinois, USA

    Kevin T. McVary

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

DiGiorgio, L., Sadeghi-Nejad, H. (2016). Peyronie’s Disease: Surgical Therapy. In: Köhler, T., McVary, K. (eds) Contemporary Treatment of Erectile Dysfunction. Contemporary Endocrinology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-31587-4_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31587-4_23

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-31585-0

  • Online ISBN: 978-3-319-31587-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation